- Report
- October 2024
- 193 Pages
Global
From €3312EUR$3,545USD£2,802GBP
€3680EUR$3,939USD£3,113GBP
- Report
- March 2025
- 187 Pages
Global
From €3312EUR$3,545USD£2,802GBP
€3680EUR$3,939USD£3,113GBP
- Report
- August 2024
- 146 Pages
Global
From €2802EUR$2,999USD£2,370GBP
- Report
- April 2025
- 238 Pages
Global
From €4624EUR$4,950USD£3,912GBP
- Report
- August 2024
- 175 Pages
Global
From €4671EUR$5,000USD£3,952GBP
- Report
- April 2024
- 164 Pages
Global
From €3363EUR$3,600USD£2,845GBP
- Report
- January 2024
- 200 Pages
Global
From €3877EUR$4,150USD£3,280GBP
- Report
- April 2023
- 255 Pages
Global
From €2336EUR$2,500USD£1,976GBP
- Report
- November 2023
- 173 Pages
Global
From €4624EUR$4,950USD£3,912GBP
- Report
- August 2023
- 100 Pages
Global
From €3500EUR$4,013USD£3,065GBP
The Intravenous Access market is a segment of the Medical Devices industry that focuses on the delivery of fluids, medications, and nutrients directly into a patient's bloodstream. This is typically done through a catheter, which is inserted into a vein and connected to a bag of fluid. Intravenous Access devices are used in a variety of medical settings, including hospitals, clinics, and home care.
The market is driven by the increasing prevalence of chronic diseases, such as diabetes and cancer, as well as the growing demand for minimally invasive treatments. Additionally, technological advancements in the field have enabled the development of more efficient and cost-effective devices.
Notable companies in the Intravenous Access market include B. Braun, Baxter, Smiths Medical, AngioDynamics, and Teleflex. Show Less Read more